Topics

Roche's Tecentriq combo scores FDA approval in non-small cell lung cancer http://bit.ly/2r3uclB pic.twitter.com/MKGc7X54hR

12:00 EST 4 Dec 2019 | Pharmafile

Roche's Tecentriq combo scores FDA approval in non-small cell lung cancer http://bit.ly/2r3uclB 

Original Article: Roche's Tecentriq combo scores FDA approval in non-small cell lung cancer http://bit.ly/2r3uclB pic.twitter.com/MKGc7X54hR

NEXT ARTICLE

More From BioPortfolio on "Roche's Tecentriq combo scores FDA approval in non-small cell lung cancer http://bit.ly/2r3uclB pic.twitter.com/MKGc7X54hR"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...